Zai Lab (ZLAB) Prepaid Assets (2016 - 2026)
Zai Lab (ZLAB) posted Prepaid Assets of $35.5 million for Q1 2026, down 3.35% sequentially from $36.7 million in Q4 2025, and down 19.2% YoY from $43.9 million in Q1 2025.
Zai Lab (ZLAB) Prepaid Assets (2016 - 2026) Analysis & Trends
Zai Lab has reported Prepaid Assets for 11 years, with the latest figure at $35.5 million in Q1 2026.
- Quarterly Prepaid Assets fell 19.2% year-over-year to $35.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.5 million (down 19.2% YoY) and the FY2025 annual result came in at $36.7 million, down 11.66% from the prior year.
- Prepaid Assets fell to $35.5 million in Q1 2026 per ZLAB's latest filing, from $36.7 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $43.9 million in Q1 2025 and troughed at $16.5 million in Q1 2022.
- A 5-year average of $32.3 million and a median of $35.7 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets soared 159.38% in 2023, then slumped 47.2% in 2024.
- Over 5 years, Prepaid Assets stood at $35.7 million in 2022, then slumped by 35.54% to $23.0 million in 2023, then jumped by 80.59% to $41.5 million in 2024, then fell by 11.66% to $36.7 million in 2025, then slipped by 3.35% to $35.5 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $35.5 million, $36.7 million, and $43.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.64 Mn |
| Mar 31, 2026 | 35.45 Mn |
| Dec 31, 2025 | 36.68 Mn |
| Sep 30, 2025 | 43.65 Mn |
| Jun 30, 2025 | 40.75 Mn |
| Mar 31, 2025 | 43.88 Mn |
| Dec 31, 2024 | 41.53 Mn |
| Sep 30, 2024 | 35.67 Mn |
| Jun 30, 2024 | 20.29 Mn |
| Mar 31, 2024 | 24.22 Mn |
| Dec 31, 2023 | 23.00 Mn |
| Sep 30, 2023 | 29.82 Mn |
| Jun 30, 2023 | 38.43 Mn |
| Mar 31, 2023 | 42.77 Mn |
| Dec 31, 2022 | 35.67 Mn |
| Sep 30, 2022 | 22.16 Mn |
| Jun 30, 2022 | 17.97 Mn |
| Mar 31, 2022 | 16.49 Mn |
| Dec 31, 2021 | 18.02 Mn |
| Sep 30, 2021 | 17.08 Mn |